Navigation Links
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
Date:3/24/2008

ZFN Technology has Broad Applications in Research, Drug Development and

Therapeutics

ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating the use of Sangamo's zinc finger DNA-binding protein nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in research and therapeutic product development.

This work, which was carried out in collaboration with scientists from Pfizer Inc, represents a significant advance in the specificity and efficiency of the generation of cell lines in which an individual gene has been "knocked-out" or deleted. Such cell lines are powerful tools that are widely used in research to identify a gene's function, in drug development to screen potential drug candidates and for production of recombinant proteins. In addition, Sangamo is using this technology to develop ZFP Therapeutics(TM) for the treatment of HIV/AIDS and brain cancer. Sigma-Aldrich is Sangamo's exclusive licensee for this technology in the laboratory research reagent field.

"These data have broad implications for experimental and translational biology, biotechnology and medicine," said Philip Gregory, D.Phil., Sangamo's vice president of research. "The generation of knockouts in basic research and industrial cell line engineering has been severely limited by the absence of efficient
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
6. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
7. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
10. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
11. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... PARIS, November 6 , - ...Linezolid for the,Treatment of Multi-Resistant Sta...vexel, a speciality pharmaceutical company focused...tics designed to overcome the significant global,p...at its most advanced oral,antibacterial NXL103 (fl...
(Date:11/5/2009)...OINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCal...PT ), a specialty pharmaceutical company focused o...tary products that address important therapeutic n... it will host a webcast and teleconference with ma...esults on Thursday, November 12, 2009, at 5:00 p.m...
(Date:11/5/2009)...ULLERTON, Calif., Nov. 5 Renee Cob...ate professor of dermatology at the University of ...nts are experiencing tremendous results with Therm...ed for skin tightening and contouring, features a ...efficacy and improves patient comfort. ,, "The...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2What are the most effective ways of promoting physical exercise in adults 3F 51564 1What are the most effective ways of promoting physical exercise in adults 3F 51564 2What are the most effective ways of promoting physical exercise in adults 3F 51564 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 1Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 2Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 3Novel drug discovery tool could identify promising new therapies for Parkinsons disease 13001 4Pelosi Statement on Appointment of Dr Regina Benjamin as Surgeon General of the United States 51560 1
...or Cancer Research meeting indicate that technolo...-water-soluble drugs to treat cancer and possibly ...r Pharmaceuticals today,reported results on a nove...pable of dissolving in water (hydrophobic drugs) i...ation. These findings allow the company to,combine...
...MOND, Va., April 16 Insmed Inc. (Nasdaq:,INSM), a...ticals, today,announced that it has received appro...care products Regulatory Agency (MHRA) to initiate...n biologic (FOB) product candidate.,Insmed,s INS-1...a follow-on,biologic of the FDA-approved product N...
Other Medicine Technology:Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 2Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4
(Date:11/8/2009)...te Shows Who Sides With Working Families vs. Insur...ewswire-USNewswire/ -- On the heels of an historic...or a good, balanced health care reform bill, the P...r state,s U.S. representatives voted on HR 3962, t...The legislation, which passed Saturday evening by ...
(Date:11/7/2009)..., The American Medical ...Rush Award for Citizenship and Community Service t...icago, IL. The award recognizes physicians who hav... duty to make an outstanding public service contri...d the award today during the opening session of th...
(Date:11/7/2009).... 7 With the final Hous...tremists are holding the entire bill hostage to fu...g that the bill go far beyond the status quo restr...o the original bill. In an outrageous amendment, ...ternoon, antichoice Democrats are demanding explic...
(Date:11/7/2009)...e Public Relations Society of America (PRSA) will ...Gage Lofgren, senior vice president of Brand Strat...tonight at a ceremony at PRSA,s 2009 International...o the PRSA College of Fellows is one of the profes...rman, APR, SAGE, Fellow PRSA, and 2009 chair of th...
(Date:11/7/2009)... Forget ‘sweatox’ or ‘Boytox&...age of the anti-ageing jab ‘Breastox’ ... the décolletage, can reduce the appearance...round the breasts, leaving smoother, younger-looki...er 7, 2009 -- Transform, the UK’s largest gr...
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:UK Boobs Get a Boost with 'Breastox' 2
... after revelation that Peanut Corp. of America shi...break, FDA announces , , FRIDAY, Jan. 30 (...criminal investigation into the salmonella outbrea...e criminal violations at the Georgia processing pl...
...an. 30 Americans resolving to eat healthier and m...e also likely to look for ways to trim their groce...reasing nutritional intake? Dr. Praeger,s Sensible...hier lifestyle choices during tough economic times...
...S. Vincent Grasso, a member of the Stevens Healthc...rd was selected to lead the technical team on a $5...AA compliant, web-based data entry and reporting p...or HIV Women of Color. The grant proposal brings t...
...matic brain injury (TBI) has been identified as th...nistan. , TBI is known to cause deficits in mem...s in conjunction with post-traumatic stress disord...gathered by the Veterans Administration,s (VA) Qua...
...rnors Association Center meeting highlights IBC,s ...nitiative in southeastern PA , , PHILADELPHIA, Ja...nt of Health Services Richard Snyder, MD, yesterda...nter meeting for Best Practices in New Orleans. La...
.... 30 Stryker Corporation (NYSE: SYK ) announced...Wednesday, May 20, 2009, at 8:00 a.m. Eastern Time..., President and Chief Executive Officer, will host...r,s website at www.stryker.com via the For Inves...
Other Medicine News:Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 2Health News:U.S. Launches Criminal Probe Into Salmonella Outbreak 3Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 2Health News:Lower Your Grocery Bill, Improve Health In 2009: Top Tips From Dr. Praeger's Sensible Foods 3Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 2Health News:Grasso leads technical team's response to HHS HIV/AIDS Bureau announcement 3Health News:Study of Iraq veterans' traumatic brain injuries to be conducted by UB researchers 2Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 2Health News:Patient-Centered Medical Homes Can Improve Care, Reduce Costs; Independence Blue Cross Medical Executive Discusses Innovative PA Program With Nation's Health Care Policy Makers 3Health News:Stryker to Host Analyst Meeting 2
...e any trocar system you've ever seen., ,The OnePo...n one designed to be versatile, operationally fle...., ,By offering options in disposability and blad...ctively address the individual preferences of the ...
Reusable Thoracoscopy Cannula
...separate components: an exchange rod, a dilating o...ent trocar sleeve. The exchange rod is a rigid cyl... dilating obturator is tapered and threaded at the...the 10/11mm or the 12mm ENDOPATH surgical trocar. ...
...trocar should be a seamless part of any procedure,...e process. So we spent over three years designing ...g surgeons., ,Introducing the ENDOPATH® Xcel&...unencumbered, hassle-free, laparoscopic access., ...
Medicine Products: